Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 25)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/AOMCL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169  View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of OMNICELL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: OMNICELL -- OMCL1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ABCO , MDRX , CFN , CRA , CRVL , ECLP , OMCL , WBMD -- MEDICAL SERVICES3$4  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for OMCL: the economy's impact on OMCL's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
31-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Omnicell Incorporated42$65  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: OMNICELL INC5$25  View Abstract
29-Jan-10Caris & Companyleo CarpioOMCL - Strong 4Q09 Performance and Conservative 2010 Guidance9$254 Stars  View Abstract
Next 15

Brokerage Reports (Showing 1 to 3 of 3)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
29-Jan-10Caris & Companyleo CarpioOMCL - Strong 4Q09 Performance and Conservative 2010 Guidance9$254 Stars  View Abstract
26-Jan-10Caris & Companyleo CarpioOMCL-4Q09 Earnings Preview; Good Q with Focus on 20106$254 Stars  View Abstract
25-Jan-10Caris & Companyleo CarpioOMCL-Solid Hospital Medication Cabinet Franchise8$254 Stars  View Abstract

Independent Reports (Showing 1 to 10 of 22)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/AOMCL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of OMNICELL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: OMNICELL -- OMCL1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ABCO , MDRX , CFN , CRA , CRVL , ECLP , OMCL , WBMD -- MEDICAL SERVICES3$4View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for OMCL: the economy's impact on OMCL's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
31-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Omnicell Incorporated42$65View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: OMNICELL INC5$25View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: OMNICELL INC5$25View Abstract
Next 12

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.